approval
saveITOVEBI (INAVOLISIB) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalSep 17, 2024
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalSep 12, 2024
comments(0)
5-min edit window · permanent after that